1 |
England C, Trejomartinez J, Perezsanchez P, Karki U, Xu J. Plants as Biofactories for Therapeutic Proteins and Antiviral Compounds to Combat COVID-19. Life 2023;13:617. [DOI: 10.3390/life13030617] [Reference Citation Analysis]
|
2 |
Singh DD, Han I, Choi EH, Yadav DK. A Clinical Update on SARS-CoV-2: Pathology and Development of Potential Inhibitors. Curr Issues Mol Biol 2023;45:400-33. [PMID: 36661514 DOI: 10.3390/cimb45010028] [Reference Citation Analysis]
|
3 |
Margolin E, Schäfer G, Allen JD, Gers S, Woodward J, Sutherland AD, Blumenthal M, Meyers A, Shaw ML, Preiser W, Strasser R, Crispin M, Williamson AL, Rybicki EP, Chapman R. A plant-produced SARS-CoV-2 spike protein elicits heterologous immunity in hamsters. Front Plant Sci 2023;14:1146234. [PMID: 36959936 DOI: 10.3389/fpls.2023.1146234] [Reference Citation Analysis]
|
4 |
Aloor A, Aradhya R, Venugopal P, Gopalakrishnan Nair B, Suravajhala R. Glycosylation in SARS-CoV-2 Variants: A path to Infection and Recovery. Biochem Pharmacol 2022;:115335. [PMID: 36328134 DOI: 10.1016/j.bcp.2022.115335] [Reference Citation Analysis]
|
5 |
Rebelo BA, Folgado A, Ferreira AC, Abranches R. Production of the SARS-CoV-2 Spike protein and its Receptor Binding Domain in plant cell suspension cultures. Front Plant Sci 2022;13:995429. [DOI: 10.3389/fpls.2022.995429] [Reference Citation Analysis]
|
6 |
Bolaños-martínez OC, Strasser R. Plant-made poliovirus vaccines – Safe alternatives for global vaccination. Front Plant Sci 2022;13:1046346. [DOI: 10.3389/fpls.2022.1046346] [Reference Citation Analysis]
|